Chenguang Biotech Group Co Ltd
SZSE:300138
Income Statement
Earnings Waterfall
Chenguang Biotech Group Co Ltd
Revenue
|
6.7B
CNY
|
Cost of Revenue
|
-5.8B
CNY
|
Gross Profit
|
840.9m
CNY
|
Operating Expenses
|
-290.1m
CNY
|
Operating Income
|
550.8m
CNY
|
Other Expenses
|
-55.2m
CNY
|
Net Income
|
495.6m
CNY
|
Income Statement
Chenguang Biotech Group Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 107
N/A
|
1 186
+7%
|
1 131
-5%
|
1 174
+4%
|
1 238
+5%
|
1 207
-2%
|
1 205
0%
|
1 287
+7%
|
1 246
-3%
|
1 268
+2%
|
1 474
+16%
|
1 636
+11%
|
1 824
+12%
|
2 141
+17%
|
2 259
+6%
|
2 385
+6%
|
2 780
+17%
|
2 772
0%
|
2 807
+1%
|
2 779
-1%
|
2 799
+1%
|
3 063
+9%
|
3 139
+2%
|
3 378
+8%
|
3 226
-4%
|
3 265
+1%
|
3 288
+1%
|
3 481
+6%
|
3 667
+5%
|
3 913
+7%
|
4 188
+7%
|
4 186
0%
|
4 410
+5%
|
4 874
+11%
|
5 446
+12%
|
6 002
+10%
|
6 465
+8%
|
6 296
-3%
|
6 529
+4%
|
6 737
+3%
|
6 669
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(964)
|
(1 040)
|
(992)
|
(1 054)
|
(1 103)
|
(1 078)
|
(1 072)
|
(1 120)
|
(1 091)
|
(1 094)
|
(1 271)
|
(1 424)
|
(1 562)
|
(1 848)
|
(1 927)
|
(2 007)
|
(2 400)
|
(2 426)
|
(2 445)
|
(2 420)
|
(2 420)
|
(2 631)
|
(2 688)
|
(2 881)
|
(2 698)
|
(2 691)
|
(2 683)
|
(2 820)
|
(2 958)
|
(3 280)
|
(3 563)
|
(3 618)
|
(3 855)
|
(4 173)
|
(4 681)
|
(5 180)
|
(5 592)
|
(5 449)
|
(5 651)
|
(5 876)
|
(5 828)
|
|
Gross Profit |
143
N/A
|
146
+2%
|
138
-5%
|
120
-13%
|
135
+12%
|
129
-5%
|
134
+4%
|
167
+25%
|
155
-7%
|
174
+13%
|
203
+17%
|
212
+5%
|
263
+24%
|
293
+12%
|
333
+14%
|
377
+13%
|
380
+1%
|
347
-9%
|
363
+5%
|
359
-1%
|
379
+6%
|
433
+14%
|
451
+4%
|
497
+10%
|
528
+6%
|
574
+9%
|
606
+5%
|
661
+9%
|
709
+7%
|
633
-11%
|
625
-1%
|
568
-9%
|
555
-2%
|
700
+26%
|
765
+9%
|
821
+7%
|
873
+6%
|
847
-3%
|
878
+4%
|
861
-2%
|
841
-2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(114)
|
(110)
|
(112)
|
(101)
|
(98)
|
(98)
|
(104)
|
(104)
|
(98)
|
(111)
|
(116)
|
(128)
|
(157)
|
(202)
|
(233)
|
(252)
|
(234)
|
(186)
|
(170)
|
(164)
|
(193)
|
(251)
|
(262)
|
(290)
|
(310)
|
(320)
|
(334)
|
(345)
|
(375)
|
(263)
|
(241)
|
(202)
|
(170)
|
(290)
|
(327)
|
(368)
|
(394)
|
(373)
|
(373)
|
(325)
|
(290)
|
|
Selling, General & Administrative |
(99)
|
(86)
|
(102)
|
(93)
|
(91)
|
(78)
|
(98)
|
(99)
|
(101)
|
(93)
|
(115)
|
(130)
|
(150)
|
(150)
|
(210)
|
(206)
|
(198)
|
(151)
|
(170)
|
(190)
|
(210)
|
(213)
|
(241)
|
(255)
|
(274)
|
(262)
|
(283)
|
(292)
|
(294)
|
(189)
|
(174)
|
(138)
|
(117)
|
(191)
|
(227)
|
(245)
|
(254)
|
(229)
|
(246)
|
(238)
|
(229)
|
|
Research & Development |
0
|
(9)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
(7)
|
(29)
|
0
|
0
|
(6)
|
(27)
|
(27)
|
(43)
|
(45)
|
(45)
|
(52)
|
(48)
|
(68)
|
(76)
|
(83)
|
(91)
|
(88)
|
(86)
|
(99)
|
(116)
|
(135)
|
(122)
|
(129)
|
(113)
|
(92)
|
|
Depreciation & Amortization |
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(47)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(16)
|
(2)
|
(10)
|
(8)
|
(7)
|
(1)
|
(6)
|
(5)
|
3
|
(1)
|
(2)
|
1
|
(7)
|
(2)
|
(23)
|
(47)
|
(29)
|
6
|
(0)
|
25
|
22
|
7
|
6
|
8
|
8
|
9
|
0
|
(4)
|
(14)
|
32
|
15
|
27
|
36
|
29
|
(1)
|
(7)
|
(5)
|
25
|
3
|
27
|
31
|
|
Operating Income |
29
N/A
|
36
+24%
|
27
-26%
|
20
-26%
|
37
+87%
|
31
-17%
|
30
-3%
|
63
+114%
|
57
-10%
|
63
+11%
|
86
+37%
|
84
-3%
|
106
+26%
|
90
-14%
|
100
+10%
|
125
+26%
|
146
+17%
|
161
+10%
|
193
+20%
|
195
+1%
|
186
-5%
|
182
-2%
|
189
+4%
|
207
+10%
|
218
+5%
|
254
+17%
|
271
+7%
|
316
+17%
|
334
+6%
|
369
+11%
|
384
+4%
|
366
-5%
|
385
+5%
|
410
+7%
|
438
+7%
|
453
+3%
|
479
+6%
|
474
-1%
|
505
+7%
|
536
+6%
|
551
+3%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(19)
|
(23)
|
(25)
|
(23)
|
(26)
|
(19)
|
(18)
|
(17)
|
(8)
|
(6)
|
(7)
|
2
|
2
|
8
|
4
|
(9)
|
(22)
|
(30)
|
(46)
|
(39)
|
(37)
|
(41)
|
(39)
|
(49)
|
(52)
|
(52)
|
(57)
|
(54)
|
(53)
|
(58)
|
(50)
|
(31)
|
(30)
|
(18)
|
(27)
|
(13)
|
(1)
|
19
|
18
|
43
|
24
|
|
Non-Reccuring Items |
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(3)
|
0
|
0
|
0
|
(2)
|
1
|
1
|
1
|
(9)
|
0
|
(0)
|
0
|
(11)
|
0
|
0
|
1
|
(7)
|
1
|
1
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
(6)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
14
|
7
|
8
|
11
|
15
|
17
|
18
|
25
|
22
|
20
|
17
|
16
|
17
|
18
|
26
|
23
|
30
|
22
|
21
|
21
|
14
|
13
|
6
|
4
|
2
|
10
|
7
|
5
|
5
|
11
|
1
|
10
|
10
|
17
|
14
|
12
|
15
|
16
|
14
|
11
|
12
|
|
Pre-Tax Income |
25
N/A
|
18
-29%
|
10
-44%
|
7
-26%
|
25
+247%
|
29
+15%
|
30
+3%
|
70
+135%
|
71
+1%
|
79
+12%
|
97
+22%
|
96
-1%
|
119
+25%
|
115
-4%
|
129
+13%
|
138
+7%
|
153
+11%
|
153
0%
|
167
+10%
|
175
+5%
|
163
-7%
|
151
-7%
|
156
+3%
|
162
+4%
|
169
+4%
|
211
+25%
|
223
+6%
|
269
+21%
|
287
+7%
|
313
+9%
|
335
+7%
|
345
+3%
|
365
+6%
|
398
+9%
|
425
+7%
|
452
+6%
|
493
+9%
|
502
+2%
|
538
+7%
|
591
+10%
|
587
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(4)
|
(7)
|
(7)
|
(4)
|
(5)
|
(9)
|
(8)
|
(15)
|
(13)
|
(11)
|
(15)
|
(10)
|
(13)
|
(15)
|
(13)
|
(31)
|
(38)
|
(24)
|
(27)
|
(18)
|
(10)
|
(9)
|
(14)
|
(5)
|
(7)
|
(21)
|
(19)
|
(37)
|
(37)
|
(47)
|
(52)
|
(42)
|
(44)
|
(47)
|
(45)
|
(50)
|
(63)
|
(66)
|
(69)
|
(80)
|
(73)
|
|
Income from Continuing Operations |
21
|
11
|
3
|
4
|
20
|
21
|
22
|
56
|
58
|
68
|
82
|
86
|
106
|
100
|
117
|
107
|
115
|
129
|
141
|
157
|
153
|
142
|
143
|
158
|
161
|
190
|
204
|
232
|
249
|
266
|
284
|
303
|
321
|
351
|
380
|
403
|
430
|
436
|
469
|
511
|
514
|
|
Income to Minority Interest |
0
|
(0)
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
(2)
|
(6)
|
(7)
|
(7)
|
(5)
|
13
|
14
|
14
|
15
|
2
|
2
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
(1)
|
(2)
|
(7)
|
(18)
|
(18)
|
|
Net Income (Common) |
21
N/A
|
11
-50%
|
3
-70%
|
4
+35%
|
21
+402%
|
22
+6%
|
24
+5%
|
57
+141%
|
59
+4%
|
69
+17%
|
80
+16%
|
79
-1%
|
99
+25%
|
93
-6%
|
111
+20%
|
120
+8%
|
129
+8%
|
143
+11%
|
155
+9%
|
159
+2%
|
155
-3%
|
145
-6%
|
146
+1%
|
162
+11%
|
165
+2%
|
194
+17%
|
206
+6%
|
235
+14%
|
252
+7%
|
272
+8%
|
289
+6%
|
308
+7%
|
325
+6%
|
352
+8%
|
380
+8%
|
403
+6%
|
429
+6%
|
434
+1%
|
462
+6%
|
492
+7%
|
496
+1%
|
|
EPS (Diluted) |
0.04
N/A
|
0.02
-50%
|
0
N/A
|
0.01
N/A
|
0.05
+400%
|
0.05
N/A
|
0.05
N/A
|
0.12
+140%
|
0.13
+8%
|
0.14
+8%
|
0.16
+14%
|
0.15
-6%
|
0.19
+27%
|
0.18
-5%
|
0.22
+22%
|
0.23
+5%
|
0.24
+4%
|
0.28
+17%
|
0.29
+4%
|
0.3
+3%
|
0.29
-3%
|
0.28
-3%
|
0.27
-4%
|
0.3
+11%
|
0.31
+3%
|
0.38
+23%
|
0.4
+5%
|
0.5
+25%
|
0.51
+2%
|
0.55
+8%
|
0.58
+5%
|
0.64
+10%
|
0.54
-16%
|
0.67
+24%
|
0.73
+9%
|
0.75
+3%
|
0.81
+8%
|
0.81
N/A
|
0.87
+7%
|
0.92
+6%
|
0.93
+1%
|